Clinical Trial Stocks List



Recent Signals

Date Stock Signal Type
2021-04-20 ATHX NR7 Range Contraction
2021-04-20 ATHX Hammer Candlestick Bullish
2021-04-20 BBC 200 DMA Support Bullish
2021-04-20 BBC Doji - Bullish? Reversal
2021-04-20 BBC Stochastic Reached Oversold Weakness
2021-04-20 BLRX Bollinger Band Squeeze Range Contraction
2021-04-20 BLRX Lower Bollinger Band Walk Weakness
2021-04-20 CARA 1,2,3 Pullback Bullish Bullish Swing Setup
2021-04-20 CARA Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-04-20 CARA NR7 Range Contraction
2021-04-20 GLSI Narrow Range Bar Range Contraction
2021-04-20 GLSI NR7-2 Range Contraction
2021-04-20 GLSI NR7 Range Contraction
2021-04-20 GLSI 1,2,3 Pullback Bullish Bullish Swing Setup
2021-04-20 GLYC NR7 Range Contraction
2021-04-20 HCM Bollinger Band Squeeze Range Contraction
2021-04-20 HCM NR7 Range Contraction
2021-04-20 ICLR Pocket Pivot Bullish Swing Setup
2021-04-20 IDRA New 52 Week Low Weakness
2021-04-20 IDRA NR7 Range Contraction
2021-04-20 IDRA NR7-2 Range Contraction
2021-04-20 IDRA Narrow Range Bar Range Contraction
2021-04-20 IDRA Spinning Top Other
2021-04-20 INBX NR7 Range Contraction
2021-04-20 INBX Lizard Bullish Bullish Day Trade Setup
2021-04-20 INBX Doji - Bullish? Reversal
2021-04-20 INBX Hammer Candlestick Bullish
2021-04-20 LPCN Bollinger Band Squeeze Range Contraction
2021-04-20 LQDA Pocket Pivot Bullish Swing Setup
2021-04-20 LQDA 50 DMA Resistance Bearish
2021-04-20 MREO Bullish Engulfing Bullish
2021-04-20 OCUL Stochastic Reached Oversold Weakness
2021-04-20 OMER Crossed Above 20 DMA Bullish
2021-04-20 OMER Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-20 OPK Bollinger Band Squeeze Range Contraction
2021-04-20 RPHM NR7 Range Contraction
2021-04-20 STTK Narrow Range Bar Range Contraction
2021-04-20 STTK NR7 Range Contraction
2021-04-20 STTK NR7-2 Range Contraction
2021-04-20 SUPN Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-04-20 SUPN NR7 Range Contraction
2021-04-20 SUPN Calm After Storm Range Contraction
2021-04-20 VBLT Stochastic Buy Signal Bullish
2021-04-20 VBLT Narrow Range Bar Range Contraction
2021-04-20 VRCA Stochastic Buy Signal Bullish
2021-04-20 VRCA Slingshot Bearish Bearish Swing Setup
2021-04-20 VTGN Bollinger Band Squeeze Range Contraction

Recent News for Clinical Trial Stocks

Date Stock Title
Apr 21 GLSI 1 Drug, 1 Mission: What Should Investors Expect for Greenwich Life Sciences?
Apr 21 IDRA The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
Apr 20 SUPN Supernus Pharmaceuticals (SUPN) Investor Presentation - Slideshow
Apr 20 ACOR J&J (JNJ) Q1 Earnings Top, COVID-19 Vaccine Brings $100M Sales
Apr 20 OCUL What You Need To Know About Ocular Therapeutix, Inc.'s (NASDAQ:OCUL) Investor Composition
Apr 20 ICLR ICON wins multiple categories in 2021 CRO Leadership Awards for the fourth year in a row
Apr 19 CARA Cannabis Stock Gainers And Losers From April 19, 2021
Apr 19 LXRX Lexicon Pharmaceuticals (LXRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Apr 19 LQDA Corporate Insiders Snap Up Shares of Liquidia Technologies
Apr 19 GLSI Greenwich LifeSciences Hires Industry Expert Dr. Christine Fischette to Lead Business Development & Advise on Commercialization
Apr 19 OMER Omeros: The Prize Is Nigh
Apr 18 RPHM Last Week's Notable Insider Buys Included Evergy, StoneMor, Tattooed Chef And More
Apr 18 LQDA Last Week's Notable Insider Buys Included Evergy, StoneMor, Tattooed Chef And More
Apr 16 ICLR Icon PLC (ICLR) Soars 4.5%: Is Further Upside Left in the Stock?
Apr 16 GLSI Trade Alert: The CEO, CFO & Director Of Greenwich LifeSciences, Inc. (NASDAQ:GLSI), Snehal Patel, Has Just Spent US$100k Buying A Few More Shares
Apr 15 ICLR Icon wins U.S. antitrust approval for PRA Health acquisition
Apr 15 MREO Our Move On Mereo BioPharma
Apr 15 ICLR Syneos Health gains following Thermo Fisher $17B deal for PPD
Apr 15 BLRX BioLineRx Announces Presentation at 2021 American Association for Cancer Research (AACR) Annual Meeting
Apr 14 ICLR PPD gains after report Thermo Fisher nearing $15B deal